» Articles » PMID: 15115864

Effect of Exacerbations on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: a 2 Year Follow Up Study

Overview
Journal Thorax
Date 2004 Apr 30
PMID 15115864
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A study was undertaken to evaluate exacerbations and their impact on the health related quality of life (HRQL) of patients with chronic obstructive pulmonary disease (COPD).

Methods: A 2 year follow up study was performed in 336 patients with COPD of mean (SD) age 66 (8.2) years and mean (SD) forced expiratory volume in 1 second (FEV(1)) 33 (8)% predicted. Spirometric tests, questions regarding exacerbations of COPD, and HRQL measurements (St George's Respiratory Questionnaire (SGRQ) and SF-12 Health Survey) were conducted at 6 month intervals.

Results: A total of 1015 exacerbations were recorded, and 103 (30.7%) patients required at least one hospital admission during the study. After adjustment for baseline characteristics and season of assessment, frequent exacerbations had a negative effect on HRQL in patients with moderate COPD (FEV(1) 35-50% predicted); the change in SGRQ total score of moderate patients with > or =3 exacerbations was almost two points per year greater (worse) than those with <3 exacerbations during the follow up (p = 0.042). For patients with severe COPD (FEV(1) <35% predicted) exacerbations had no effect on HRQL. The change in SGRQ total score of patients admitted to hospital was almost 2 points per year greater (worse) than patients not admitted, but this effect failed to show statistical significance in any severity group. There was a significant and independent seasonal effect on HRQL since SGRQ total scores were, on average, 3 points better in measurements performed in spring/summer than in those measured in the winter (p<0.001).

Conclusions: Frequent exacerbations significantly impair HRQL of patients with moderate COPD. A significant and independent effect of seasonality was also observed.

Citing Articles

Using machine learning to predict deterioration of symptoms in COPD patients within a telemonitoring program.

Moraza J, Esteban-Aizpiri C, Aramburu A, Garcia P, Sancho F, Resino S Sci Rep. 2025; 15(1):7064.

PMID: 40016298 PMC: 11868553. DOI: 10.1038/s41598-025-91762-x.


Chronic Obstructive Pulmonary Disease: Lifestyle Impact.

Mathur S, Singh P Int J Prev Med. 2025; 15:67.

PMID: 39742126 PMC: 11687689. DOI: 10.4103/ijpvm.ijpvm_297_23.


Prevalence and predictors of polypharmacy and comorbidities among patients with chronic obstructive pulmonary disease: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.

Alwafi H, Naser A, Ashoor D, Alsharif A, Aldhahir A, Alghamdi S BMC Pulm Med. 2024; 24(1):453.

PMID: 39272014 PMC: 11401255. DOI: 10.1186/s12890-024-03274-5.


Exacerbations of bronchiectasis.

De Angelis A, Johnson E, Sutharsan S, Aliberti S Eur Respir Rev. 2024; 33(173).

PMID: 39048130 PMC: 11267293. DOI: 10.1183/16000617.0085-2024.


Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease.

Johannesmeyer H, Moussavi K, Rambaran K, Kolyouthapong K Am J Med Open. 2024; 8:100027.

PMID: 39036518 PMC: 11256224. DOI: 10.1016/j.ajmo.2022.100027.


References
1.
Miravitlles M, Zalacain R, Murio C, Ferrer M, Alvarez-Sala J, Masa J . Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. Clin Drug Investig. 2007; 23(7):439-50. DOI: 10.2165/00044011-200323070-00003. View

2.
Alvarez-Sala J, Cimas E, Masa J, Miravitlles M, Molina J, Naberan K . [Recommendations for the care of the patient with chronic obstructive pulmonary disease]. Arch Bronconeumol. 2001; 37(7):269-78. DOI: 10.1016/s0300-2896(01)75089-2. View

3.
Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

4.
Spencer S, Calverley P, Burge P, Jones P . Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163(1):122-8. DOI: 10.1164/ajrccm.163.1.2005009. View

5.
Vincken W, van Noord J, Greefhorst A, Bantje T, Kesten S, Korducki L . Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J. 2002; 19(2):209-16. DOI: 10.1183/09031936.02.00238702. View